Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Anne M, Wallace"'
Autor:
Maren M. Sjaastad Andreassen, Stephane Loubrie, Michelle W. Tong, Lauren Fang, Tyler M. Seibert, Anne M. Wallace, Somaye Zare, Haydee Ojeda-Fournier, Joshua Kuperman, Michael Hahn, Neil P. Jerome, Tone F. Bathen, Ana E. Rodríguez-Soto, Anders M. Dale, Rebecca Rakow-Penner
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeDynamic contrast-enhanced MRI (DCE) and apparent diffusion coefficient (ADC) are currently used to evaluate treatment response of breast cancer. The purpose of the current study was to evaluate the three-component Restriction Spectrum Imaging
Externí odkaz:
https://doaj.org/article/51223c94fb14463c96416be583347c3c
Autor:
Julie E. Lang, Andres Forero-Torres, Douglas Yee, Christina Yau, Denise Wolf, John Park, Barbara A. Parker, A. Jo Chien, Anne M. Wallace, Rashmi Murthy, Kathy S. Albain, Erin D. Ellis, Heather Beckwith, Barbara B. Haley, Anthony D. Elias, Judy C. Boughey, Rachel L. Yung, Claudine Isaacs, Amy S. Clark, Hyo S. Han, Rita Nanda, Qamar J. Khan, Kristen K. Edmiston, Erica Stringer-Reasor, Elissa Price, Bonnie Joe, Minetta C. Liu, Lamorna Brown-Swigart, Emanuel F. Petricoin, Julia D. Wulfkuhle, Meredith Buxton, Julia L. Clennell, Ashish Sanil, Scott Berry, Smita M. Asare, Amy Wilson, Gillian L. Hirst, Ruby Singhrao, Adam L. Asare, Jeffrey B. Matthews, Michelle Melisko, Jane Perlmutter, Hope S. Rugo, W. Fraser Symmans, Laura J. van ‘t Veer, Nola M. Hylton, Angela M. DeMichele, Donald A. Berry, Laura J. Esserman
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-10 (2022)
Abstract HSP90 inhibitors destabilize oncoproteins associated with cell cycle, angiogenesis, RAS-MAPK activity, histone modification, kinases and growth factors. We evaluated the HSP90-inhibitor ganetespib in combination with standard chemotherapy in
Externí odkaz:
https://doaj.org/article/f1ec1969e2aa401dafdcc1102c26a20e
Publikováno v:
European Journal of Case Reports in Internal Medicine (2023)
A 30-year-old woman with a history of anorexia nervosa was admitted with weight loss, hypoglycaemia and electrolyte disturbances. During her admission, transaminases peaked at ALP 457 U/l, AST 817 U/l and ALT 1066 U/l. Imaging and laboratory findings
Externí odkaz:
https://doaj.org/article/fafc1ccce297472c8df90c718288f70c
Autor:
Amy S. Clark, Christina Yau, Denise M. Wolf, Emanuel F. Petricoin, Laura J. van ‘t Veer, Douglas Yee, Stacy L. Moulder, Anne M. Wallace, A. Jo Chien, Claudine Isaacs, Judy C. Boughey, Kathy S. Albain, Kathleen Kemmer, Barbara B. Haley, Hyo S. Han, Andres Forero-Torres, Anthony Elias, Julie E. Lang, Erin D. Ellis, Rachel Yung, Debu Tripathy, Rita Nanda, Julia D. Wulfkuhle, Lamorna Brown-Swigart, Rosa I. Gallagher, Teresa Helsten, Erin Roesch, Cheryl A. Ewing, Michael Alvarado, Erin P. Crane, Meredith Buxton, Julia L. Clennell, Melissa Paoloni, Smita M. Asare, Amy Wilson, Gillian L. Hirst, Ruby Singhrao, Katherine Steeg, Adam Asare, Jeffrey B. Matthews, Scott Berry, Ashish Sanil, Michelle Melisko, Jane Perlmutter, Hope S. Rugo, Richard B. Schwab, W. Fraser Symmans, Nola M. Hylton, Donald A. Berry, Laura J. Esserman, Angela M. DeMichele
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
HER2-targeted therapy improves patient’s outcome in early breast cancer. Here, the authors present the efficacy and biomarker analysis of two HER2-targeted combinations (ado-trastuzumab emtansine plus pertuzumab and paclitaxel, trastuzumab and pert
Externí odkaz:
https://doaj.org/article/e6340916dac6476fac8b24ed5afd32c1
Autor:
Douglas Yee, Claudine Isaacs, Denise M. Wolf, Christina Yau, Paul Haluska, Karthik V. Giridhar, Andres Forero-Torres, A. Jo Chien, Anne M. Wallace, Lajos Pusztai, Kathy S. Albain, Erin D. Ellis, Heather Beckwith, Barbara B. Haley, Anthony D. Elias, Judy C. Boughey, Kathleen Kemmer, Rachel L. Yung, Paula R. Pohlmann, Debu Tripathy, Amy S. Clark, Hyo S. Han, Rita Nanda, Qamar J. Khan, Kristen K. Edmiston, Emanuel F. Petricoin, Erica Stringer-Reasor, Carla I. Falkson, Melanie Majure, Rita A. Mukhtar, Teresa L. Helsten, Stacy L. Moulder, Patricia A. Robinson, Julia D. Wulfkuhle, Lamorna Brown-Swigart, Meredith Buxton, Julia L. Clennell, Melissa Paoloni, Ashish Sanil, Scott Berry, Smita M. Asare, Amy Wilson, Gillian L. Hirst, Ruby Singhrao, Adam L. Asare, Jeffrey B. Matthews, Nola M. Hylton, Angela DeMichele, Michelle Melisko, Jane Perlmutter, Hope S. Rugo, W. Fraser Symmans, Laura J. van‘t Veer, Donald A. Berry, Laura J. Esserman
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract I-SPY2 is an adaptively randomized phase 2 clinical trial evaluating novel agents in combination with standard-of-care paclitaxel followed by doxorubicin and cyclophosphamide in the neoadjuvant treatment of breast cancer. Ganitumab is a mono
Externí odkaz:
https://doaj.org/article/784de0fabd374658a9d09088fa4a5ee8
Autor:
Rodney A. Gabriel, John J. Finneran, Matthew W. Swisher, Engy T. Said, Jacklynn F. Sztain, Bahareh Khatibi, Anne M. Wallace, Ava Hosseini, Andrea M. Trescot, Brian M. Ilfeld
Publikováno v:
Korean Journal of Anesthesiology, Vol 73, Iss 2, Pp 163-168 (2020)
Background Acute post-mastectomy pain is frequently challenging to adequately treat with local anesthetic-based regional anesthesia techniques due to its relatively long duration measured in multiple weeks. Case We report three cases in which preoper
Externí odkaz:
https://doaj.org/article/c85437b3fa6c467d97ce322e85c78bda
Publikováno v:
Archives of Breast Cancer (2021)
NA
Externí odkaz:
https://doaj.org/article/c6e81f0027d243019e1a4ab2d4a73524
Publikováno v:
Surgery. 173:305-311
Breast cancer mortality after ductal carcinoma in situ is rare, making it difficult to predict which patients are at risk and to identify whether risk factors for this outcome are the same as those for invasive recurrence. We aimed to identify whethe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a24d2ab832dd4c8d95d78b5b03bffbee
https://doi.org/10.1016/j.surg.2022.10.009
https://doi.org/10.1016/j.surg.2022.10.009
Autor:
Brian M, Ilfeld, John J, Finneran, Matthew W, Swisher, Engy T, Said, Rodney A, Gabriel, Jacklynn F, Sztain, Bahareh, Khatibi, Ava, Armani, Andrea, Trescot, Michael C, Donohue, Adam, Schaar, Anne M, Wallace
Publikováno v:
Anesthesiology. 137:529-542
Background Ultrasound-guided percutaneous cryoneurolysis is an analgesic technique in which a percutaneous probe is used to reversibly ablate a peripheral nerve(s) using exceptionally low temperature, and has yet to be evaluated with randomized, cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84a2b99cdfa1bb3db0a4cc5616266d46
https://doi.org/10.1097/aln.0000000000004334
https://doi.org/10.1097/aln.0000000000004334
Autor:
Brian M Ilfeld, John J Finneran, David Dalstrom, Anne M Wallace, Baharin Abdullah, Engy T Said
Publikováno v:
Regional anesthesia and pain medicine, vol 47, iss 9
BackgroundFollowing outpatient surgery, it is often difficult to provide adequate analgesia while concurrently minimizing opioid requirements. Ultrasound-guided percutaneous peripheral nerve stimulation has been proposed as an analgesic, but requires
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38d6b2026967e43b835e4d6a736e948c
https://doi.org/10.1136/rapm-2022-103777
https://doi.org/10.1136/rapm-2022-103777